home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Early Treatment of HIV Infection Can Boost Functional Immune Response.

 
  September, 28 2000 3:22
your information resource in human molecular genetics
 
     
HELPING HAND AGAINST HIV

Virus-specific T-helper cells are thought to be crucial for controlling HIV levels. This week Nature (VOL. 407 NO. 6803 DATED 28 SEPTEMBER 2000, pp. 523-526), Bruce Walker and colleagues at Harvard Medical School in Boston, Massachusetts, show that early treatment of HIV infection can boost this immune response.

Eight HIV patients stopped taking drug therapy and were carefully monitored. In all cases, their bodies could keep the viral numbers below a stable, manageable level — at least temporarily. Drug therapy was restarted in some patients whose viral load rose significantly, but over half are still keeping HIV in check some six months later.

Increased levels of both virus-specific T lymphocytes and T-helper cell responses were seen in all patients. This suggests that functional immune responses can be augmented during chronic HIV infection, the researchers say, showing the importance of drug treatment during early or acute HIV infection.

CONTACT

Bruce Walker
tel +1 617 724 8332
fax +1 617 726 4691
e-mail bwalker@helix.mgh.harvard.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.